Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

Clinical trial NCT02626715 · COMPLETED

Trial details

NCT number: NCT02626715
Sponsor: Randy Windreich
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Hematopoietic Stem Cell Transplant (HSCT)

Start date: 2015-09-04
Primary completion: 2023-04-12
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.